$BCRX

Biocryst Pharmaceuticals Inc.

  • NASDAQ
  • Health Technology
  • Biotechnology
  • Manufacturing
  • Biological Product (except Diagnostic) Manufacturing

PRICE

$8.8 ▲2.684%

Last Close

VOLUME

2,337,351

DAY RANGE

8.45 - 8.83

52 WEEK

7.61 - 19.99

Join Discuss about BCRX with like-minded investors

profile
@lucullus #droscrew
recently

institutions loading up on bios during this sell off. Big pharma facing a patent cliff. $MYOV black rock tripled holding size, Bellevue doubled to close to 12%. Biotech 2nd half is going to be buyout land, MYOV, BCRX, AUPH, CLVS anything with a drug that produce revenues

102 Replies 14 👍 8 🔥

profile
@dros #droscrew
recently

Upgrades 4/18: $BIIB $CEA $CMA $COP $DAL $FUL $GPS $PBF $ZION . Downgrades 4/18: $ADM $APTV $AXTA $BCRX $CLB $CSX $CTRE $IAG $MAC $NMRK $PGR $PXD $QCOM $RDBX $RRGB $RXRX $SBRA $SIRI $SLM $TWTR $UAL $WEN

96 Replies 10 👍 12 🔥

profile
@singletary #StockTraders.NET
recently

$bcrx smoked them

110 Replies 6 👍 13 🔥

profile
@lucullus #droscrew
recently

just goes to show you Flow can be a load of crap.... i sometimes wonder if folks dont put some flow in so they can sell there positions to folks.... $BCRX lead drug is worth around $30 a share so it is not a big deal ...one of their trial candidates has been stopped

122 Replies 12 👍 13 🔥

profile
@Gary19 #droscrew
recently

$bcrx tanked big

62 Replies 14 👍 11 🔥

profile
@Gary19 #droscrew
recently

What happened to $bcrx? Just got railed

59 Replies 8 👍 11 🔥

profile
@lucullus #droscrew
recently

$BCRX had some flow yesterday and ripped higher ..... about 18,000 contracts at april 18 in total call volume

77 Replies 7 👍 14 🔥

profile
@dros #droscrew
recently

RECAP 4/7 Unusual Calls: $YANG Apr 19 C $HTZ May 27.5 C $COST Apr08 600 C $CAN Apr 6 C $MSFT Apr08 305 C $BCRX Apr 18 C $CAH Apr 59 C $LUV May 75 C $MRVL Apr 68 C $MNTS Apr 5 C $ET Apr22 11 C $KBH May 33 C

137 Replies 9 👍 9 🔥

profile
@lucullus #droscrew
recently

lot of volume in $BCRX $18 for 14th April exp

125 Replies 7 👍 12 🔥

profile
@lucullus #droscrew
recently

NICE BIG DROP IN $auph AND $bcrx i hope to picks those two up again under $15 ..... thats good for a double in a decent market i think

120 Replies 13 👍 8 🔥

GM
@gman2 #ivtrades
recently

$BCRX volume spike

109 Replies 9 👍 13 🔥

profile
@lucullus #droscrew
recently

$BCRX strong like bull

123 Replies 11 👍 9 🔥

profile
@lucullus #droscrew
recently

nice recovery with that BCRX i bought today ... AUPH not so much

123 Replies 8 👍 8 🔥

profile
@lucullus #droscrew
recently

some real bargains in biotechs with drugs on the growth phase, $MYOV,$AUPH, $BCRX EVRYONE A POTENTIAL BUYOUT

62 Replies 10 👍 13 🔥

SO
@soheil.n #StockTraders.NET
recently

$BCRx - what miss of that key level 15.6...hesitated to pull the trigger again

119 Replies 15 👍 8 🔥

SO
@soheil.n #StockTraders.NET
recently

$BCRX did a FBO too over 15.6

122 Replies 9 👍 10 🔥

SO
@soheil.n #StockTraders.NET
recently

$BCRX - hovering around key 15.6

77 Replies 8 👍 15 🔥

SO
@soheil.n #StockTraders.NET
recently

on $BCRX - once 15.5s cracks there isn't much support until mid 14s....

104 Replies 15 👍 7 🔥

SO
@soheil.n #StockTraders.NET
recently

watchlist: $F - eyeing the pop and rejection towards 25 $LCID - if it flushes off open will look to long for a bounce....if it has a strong bounce off open will look to ss in the 42.5-43.5 area $BCRX - looking for a pop towards 16.2-.4 for further unwind

56 Replies 10 👍 6 🔥

SO
@soheil.n #StockTraders.NET
recently

stopped out $BCRX - small loss

135 Replies 12 👍 6 🔥

SO
@soheil.n #StockTraders.NET
recently

next add under 16.1 with a stop under 16s > @soheil.n said: longed small $BCRX at the bottom of channel

58 Replies 14 👍 7 🔥

SO
@soheil.n #StockTraders.NET
recently

longed small $BCRX at the bottom of channel

150 Replies 11 👍 15 🔥

profile
@singletary #StockTraders.NET
recently

$bcrx back near lows

118 Replies 13 👍 9 🔥

SO
@soheil.n #StockTraders.NET
recently

yeah i agree...options expiry is next week...nothing for tomorrow...and just consolidating near the highs for now > @singletary said: $bcrx think trade will be next week

52 Replies 14 👍 12 🔥

profile
@singletary #StockTraders.NET
recently

$bcrx think trade will be next week

56 Replies 6 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

damn $BCRX

80 Replies 10 👍 10 🔥

profile
@singletary #StockTraders.NET
recently

$pik $bcrx fails

136 Replies 10 👍 8 🔥

SO
@soheil.n #StockTraders.NET
recently

$BCRX - broke trend

82 Replies 14 👍 15 🔥

profile
@singletary #StockTraders.NET
recently

$bcrx hod great call. hope kept some safe

128 Replies 14 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

$f and $BCRX both strong in this market

112 Replies 7 👍 15 🔥

profile
@singletary #StockTraders.NET
recently

example $bcrx $absi $znga nothing there for me yet. but I see potential setups that probably won't set up but I have eyes there

126 Replies 15 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

damn $BCRX would have been a good add

104 Replies 8 👍 12 🔥

profile
@singletary #StockTraders.NET
recently

$bcrx 17+ would be nice

98 Replies 7 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

$BCRX lets go

95 Replies 9 👍 8 🔥

profile
@maletone #StockTraders.NET
recently

migth spill $BCRX

74 Replies 8 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

doing the same thing as yesterday > @soheil.n said: $BCRX about to crack

60 Replies 11 👍 13 🔥

SO
@soheil.n #StockTraders.NET
recently

$BCRX about to crack

117 Replies 12 👍 6 🔥

profile
@maletone #StockTraders.NET
recently

$BCRX has been losing steam if it breaks out above 17.5 then i would be out

98 Replies 9 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

starter on $BCRX

119 Replies 12 👍 11 🔥

SO
@soheil.n #StockTraders.NET
recently

to add the #ThurFri options play: $F - has the highet OI for 25 so chances that it may push towards that for it to fail on Friday is high $LCID- it's very close b/w 45 highest and 48 second highest > @soheil.n said: Watchlist: $LCID - $45.6s key : will trade long/short base on that level $F - eyeing 24.8-25 ...will depend on SPY...it may push to new high and then come back in....24.2-.3s is the key to further unwind $BCRX - 16.2 - 17.2 is the channel will play it either way using the break of the channel

46 Replies 11 👍 10 🔥

profile
@maletone #StockTraders.NET
recently

$ADGI, $RELI, $CFVI, $immx, $OLB, $BCRX

103 Replies 7 👍 12 🔥

SO
@soheil.n #StockTraders.NET
recently

Watchlist: $LCID - $45.6s key : will trade long/short base on that level $F - eyeing 24.8-25 ...will depend on SPY...it may push to new high and then come back in....24.2-.3s is the key to further unwind $BCRX - 16.2 - 17.2 is the channel will play it either way using the break of the channel

86 Replies 9 👍 13 🔥

profile
@singletary #StockTraders.NET
recently

$bcrx looked like a long all day to me. didn't go up, but held well at close

139 Replies 12 👍 9 🔥

ST
@stevengo #StockTraders.NET
recently

Did you kill $BCRX @maletone

96 Replies 15 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

nice on $BCRX

75 Replies 6 👍 7 🔥

profile
@maletone #StockTraders.NET
recently

$BCRX failing

45 Replies 12 👍 6 🔥

SO
@soheil.n #StockTraders.NET
recently

may look to ss $BCRX if it pushes to 17

119 Replies 8 👍 11 🔥

profile
@singletary #StockTraders.NET
recently

$bcrx make sure to have a plan

129 Replies 8 👍 9 🔥

SO
@soheil.n #StockTraders.NET
recently

tell me about it > @maletone said: covered that $BCRX to soon

77 Replies 8 👍 9 🔥

profile
@maletone #StockTraders.NET
recently

covered that $BCRX to soon

87 Replies 7 👍 8 🔥

Key Metrics

Market Cap

1.63 B

Beta

1.34

Avg. Volume

4.68 M

Shares Outstanding

185.58 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-04

Next Dividend Date

Company Information

BioCryst Pharmaceuticals discovers novel, oral, small-molecule medicines that treat rare diseases in which significant unmet medical needs exist and an enzyme plays a key role in the biological pathway of the disease. Oral, once-daily ORLADEYO™ (berotralstat) is approved in the United States and Japan for the prevention of HAE attacks in adults and pediatric patients 12 years and older, and under regulatory review for approval in the European Union and United Kingdom. BioCryst has several ongoing development programs including BCX9930, an oral Factor D inhibitor for the treatment of complement-mediated diseases, BCX9250, an ALK-2 inhibitor for the treatment of fibrodysplasia ossificans progressiva, and galidesivir, a potential treatment for Marburg virus disease and Yellow Fever. RAPIVAB® (peramivir injection), a viral neuraminidase inhibitor for the treatment of influenza, has received regulatory approval in the U.S., Canada, Australia, Japan, Taiwan and Korea. Post-marketing commitments for RAPIVAB are ongoing.

CEO: Jon Stonehouse

Website:

HQ: 4505 Emperor Blvd Ste 200 Durham, 27703-8457 North Carolina

Related News